{"id":79849,"date":"2024-11-18T10:02:47","date_gmt":"2024-11-18T10:02:47","guid":{"rendered":"https:\/\/www.cofb.org\/?p=79849"},"modified":"2024-11-18T10:13:09","modified_gmt":"2024-11-18T10:13:09","slug":"visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","title":{"rendered":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries"},"content":{"rendered":"\n

El passat 25 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong>, amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)<\/a>, <\/strong>va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\u201d <\/strong>amb el patrocini de Boehringer Ingelheim<\/a>. La formaci\u00f3, adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries<\/strong>, va ser impartida per professionals sanitaris de diferents especialitats<\/strong>.  <\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Els objectius<\/strong> de la formaci\u00f3 van ser revisar les estrat\u00e8gies del sistema sanitari d\u2019atenci\u00f3 a la cronicitat<\/strong>, con\u00e8ixer la relaci\u00f3 entre l\u2019eix cardiorenal metab\u00f2lic amb la insufici\u00e8ncia renal<\/strong>, card\u00edaca <\/strong>i la diabetis mellitus<\/strong> i compartir experi\u00e8ncies pr\u00e0ctiques reals<\/strong> portades a terme al territori.<\/p>\n\n\n\n

Estrat\u00e8gies d\u2019atenci\u00f3 a la cronicitat<\/strong><\/h2>\n\n\n\n

La vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB, Cristina Morales<\/strong>, va introduir la formaci\u00f3 que ofereix una \u201cvisi\u00f3 multidisciplin\u00e0ria sobre la import\u00e0ncia del maneig del pacient cardiorenal metab\u00f2lic\u201d<\/strong>. Morales va donar pas a la primera ponent de la jornada, la Dra.<\/strong> Nuria Molist,<\/strong> metgessa de la Unitat Geri\u00e0trica d\u2019Aguts de la Fundaci\u00f3 Hospital de la Santa Creu de Vic i coordinadora del Grup de Recerca en Cronicitat de la Catalunya Central, que va parlar sobre les estrat\u00e8gies d\u2019atenci\u00f3 a la cronicitat en global. <\/strong>\u201cEls pacients cardiorenals s\u00f3n pacients amb patologia cr\u00f2nica i multimorbiditats\u201d, va indicar la Dra. Molist. Pel que fa a la medicaci\u00f3 de les persones grans, la metgessa va assegurar que \u201cfins a m\u00e9s del 90% de persones d\u2019edat avan\u00e7ada es poden detectar discrep\u00e0ncies en la seva medicaci\u00f3 al cap de 7 dies d\u2019alta d\u2019un hospital\u201d<\/strong>.<\/p>\n\n\n\n

\"Cristina<\/a>
Cristina Morales i Nuria Molist introduint la formaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

En relaci\u00f3 amb l’atenci\u00f3 a les persones amb cronicitat<\/strong>, la Dra. Molist va explicar que cal passar “d\u2019una atenci\u00f3 centrada en la malaltia<\/strong>, estandarditzada i fragmentada, a una atenci\u00f3 centrada en la persona<\/strong>, individualitzada, integrada i basada en l\u2019evid\u00e8ncia”. Alhora, tamb\u00e9 va comentar que per individualitzar l\u2019atenci\u00f3 \u00e9s necessari basar-se “en la situaci\u00f3 basal, en l\u2019objectiu terap\u00e8utic individual i en l\u2019evid\u00e8ncia existent\u201d.<\/p>\n\n\n\n

Malaltia renal cr\u00f2nica i la seva relaci\u00f3 amb l\u2019eix cardiometab\u00f2lic<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3 va intervenir el Dr. Jordi Bover<\/strong>, cap del Servei de Nefrologia de l\u2019Hospital Germans Trias i Pujol, per abordar la insufici\u00e8ncia renal cr\u00f2nica i la seva relaci\u00f3 amb l\u2019eix cardiometab\u00f2lic. <\/strong>Durant la seva exposici\u00f3, va afirmar que “la malaltia renal cr\u00f2nica \u00e9s la m\u00e9s gran epid\u00e8mia cl\u00ednica que s\u2019apropa (despr\u00e9s de l\u2019Alzheimer) i ja tenim mitjans indubtables que la poden disminuir\u201d<\/strong>.<\/p>\n\n\n\n

\"Jordi<\/a>
Jordi Bover en un moment de la seva presentaci\u00f3. <\/figcaption><\/figure>\n\n\n\n

El doctor tamb\u00e9 va definir i classificar la malaltia renal cr\u00f2nica<\/strong>, va parlar sobre la import\u00e0ncia de l\u2019alb\u00famina i la creatinina a l’orina<\/strong>, i va fer refer\u00e8ncia a l\u2019epidemiologia i la prevalen\u00e7a d\u2019aquesta patologia<\/strong>, la nefro-cardioprotecci\u00f3 i el realisme-nihilisme terap\u00e8utic.<\/strong><\/p>\n\n\n\n

Insufici\u00e8ncia card\u00edaca i la seva relaci\u00f3 amb l\u2019eix renal metab\u00f2lic<\/strong><\/h2>\n\n\n\n

Per la seva banda, Antonio S\u00e1nchez, <\/strong>cap de servei de Cardiologia del Consorci Sanitari de Terrassa, va exposar una situaci\u00f3 “cada vegada m\u00e9s freq\u00fcent”<\/strong>, que \u00e9s “l\u2019associaci\u00f3 entre la malaltia cardiovascular, la insufici\u00e8ncia card\u00edaca i l\u2019obesitat\u201d<\/strong>. \u00c9s a dir, \u201csobre com passem d\u2019una persona sana, activa i saludable a una persona amb sobrep\u00e8s i exc\u00e9s de teixit adip\u00f3s”. D’aquesta manera, el doctor va indicar que “al llarg del temps acaba donant lloc a la pres\u00e8ncia de factors de risc com la hipertensi\u00f3, la diabetis o la malaltia renal\u201d<\/strong>. I, posteriorment, \u201ces pot veure en proves diagn\u00f2stiques l\u2019afectaci\u00f3 dels \u00f2rgans diana com el cor, el rony\u00f3, els vasos que acaben provocant malalties cardiovasculars com la insufici\u00e8ncia card\u00edaca, entre d\u2019altres\u201d<\/strong>.<\/p>\n\n\n\n

\"Antonio<\/a>
Antonio S\u00e1nchez impartint la seva sessi\u00f3 sobre la insufici\u00e8ncia card\u00edaca i la seva relaci\u00f3 amb l’eix metab\u00f2lic. <\/figcaption><\/figure>\n\n\n\n

En aquest sentit, el Dr. S\u00e1nchez va centrar-se en tres parts ben diferenciades sobre la insufici\u00e8ncia card\u00edaca<\/strong>: en primer lloc, va especificar quin \u00e9s i el seu impacte a Catalunya<\/strong>; en segon lloc, va abordar l\u2019eix cardiometab\u00f2lic<\/strong>, \u00e9s a dir, \u201cen com l\u2019obesitat afecta directament el sistema cardiovascular\u201d; i, en tercer lloc, va tractar les mesures terap\u00e8utiques actuals i futures.<\/p>\n\n\n\n

Diabetis mellitus i la seva relaci\u00f3 amb l\u2019eix cardiorenal<\/strong><\/h2>\n\n\n\n

A la segona part del curs, el Dr. Andreu Sim\u00f3<\/strong>, adjunt en el Servei d\u2019Endocrinologia i Nutrici\u00f3 de l\u2019Hospital M\u00fatua de Terrassa va profunditzar en la diabetis mellitus i la seva relaci\u00f3 amb l\u2019eix cardiorenal<\/strong>. \u201cLa s\u00edndrome cardiorenal \u00e9s la interconnexi\u00f3 entre el rony\u00f3, el cor, la diabetis i l\u2019obesitat\u201d,<\/strong> va descriure Sim\u00f3. Sobre aquesta s\u00edndrome, el doctor va destacar que “\u00e9s important tractar-la abans que aparegui l\u2019estadi final\u201d<\/strong>.<\/p>\n\n\n\n

\"Andreu<\/a>
Andreu Sim\u00f3 en un moment de la seva presentaci\u00f3 sobre la diabetis mellitus i la seva relaci\u00f3 amb l\u2019eix cardiorenal.<\/figcaption><\/figure>\n\n\n\n

Al llarg de la seva exposici\u00f3, el doctor va detallar la patog\u00e8nesi<\/strong> d\u2019aquesta malaltia des del punt de vista de l\u2019endocr\u00ed, els f\u00e0rmacs antihiperglucimiants<\/strong>, els iSGLT2, i va exposar quatre casos cl\u00ednics<\/strong> relacionats.  <\/p>\n\n\n\n

En darrer lloc, van intervenir la farmac\u00e8utica d\u2019atenci\u00f3 prim\u00e0ria de la Catalunya Central, Goizane Ros<\/strong>, i el metge de fam\u00edlia de l\u2019EAP Vall del Ges, Sant Vicen\u00e7 de Torell\u00f3, Xavier Costa<\/strong>, per compartir amb els assistents diferents casos cl\u00ednics de pacients cardiorenals metab\u00f2lics<\/strong>.<\/p>\n\n\n\n

\"Xavier<\/a>
Xavier Costa i Goizane Ros durant la seva exposici\u00f3. <\/figcaption><\/figure>\n\n\n\n
\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Valoraci\u00f3 de Cristina Morales, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB<\/strong><\/h2>\n\n\n\n

La vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB, Cristina<\/strong> Morales<\/strong>, va valorar positivament el curs que es va organitzar amb el prop\u00f2sit d\u2019oferir una visi\u00f3 multidisciplin\u00e0ria en l\u2019abordatge del pacient amb risc cardiovascular<\/strong>. \u201cHem complert amb el prop\u00f2sit de la formaci\u00f3 dirigida a cada nivell assistencial amb el qual pot interactuar el pacient: la farm\u00e0cia comunit\u00e0ria, l\u2019hospital\u00e0ria i d\u2019atenci\u00f3 prim\u00e0ria\u201d, va especificar la vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB.<\/p>\n\n\n\n

\"Cristina<\/a>
Cristina Morales presentant la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\u201d.<\/figcaption><\/figure>\n\n\n\n

Tanmateix, Morales va assegurar que el curs “ha generat molt inter\u00e8s i ha despertat i sensibilitzat sobre quin punt de mira ha de tenir cada perfil farmac\u00e8utic per acompanyar al pacient amb patologia cr\u00f2nica i sobre com seguir un correcte tractament\u201d<\/strong>.<\/p>\n\n\n\n

<\/p>\n\n\n\n<\/div>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Activitat organitzada conjuntament amb:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

El passat 25 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\u201d amb el patrocini de Boehringer Ingelheim. La formaci\u00f3, adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries, va […]<\/p>\n","protected":false},"author":3,"featured_media":79863,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,938,18,19,5159,5158,53,24,171,69,70,2744,2197,290,5157,523,286,129],"class_list":["post-79849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-atencio-primaria","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-diabetis-mellitus","tag-eix-cardiorenal-metabolic","tag-farmaceutics","tag-farmaceutics-comunitaris","tag-farmaceutiques","tag-farmacia-comunitaria","tag-formacio","tag-insuficiencia-cardiaca","tag-insuficiencia-renal","tag-pacient","tag-pacient-cardiorenal-metabolic","tag-professionals-sanitaris","tag-societat-catalana-de-farmacia-clinica","tag-societat-catalana-de-farmacia-clinica-scfc"],"yoast_head":"\nVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic".\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic".\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-18T10:02:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T10:13:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries\",\"datePublished\":\"2024-11-18T10:02:47+00:00\",\"dateModified\":\"2024-11-18T10:13:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"},\"wordCount\":1135,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Atenci\u00f3 prim\u00e0ria\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"diabetis mellitus\",\"eix cardiorenal metab\u00f2lic\",\"farmac\u00e8utics\",\"farmac\u00e8utics comunitaris\",\"farmac\u00e8utiques\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"insufici\u00e8ncia card\u00edaca\",\"insufici\u00e8ncia renal\",\"pacient\",\"pacient cardiorenal metab\u00f2lic\",\"professionals sanitaris\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\",\"url\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\",\"name\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"datePublished\":\"2024-11-18T10:02:47+00:00\",\"dateModified\":\"2024-11-18T10:13:09+00:00\",\"description\":\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"Cristina Morales i Nuria Molist introduint la formaci\u00f3.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","og_locale":"ca_ES","og_type":"article","og_title":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","og_url":"https:\/\/www.cofb.org\/ca\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2024-11-18T10:02:47+00:00","article_modified_time":"2024-11-18T10:13:09+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Berta Mart\u00ednez","Temps estimat de lectura":"8 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries","datePublished":"2024-11-18T10:02:47+00:00","dateModified":"2024-11-18T10:13:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"},"wordCount":1135,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","keywords":["Atenci\u00f3 farmac\u00e8utica","Atenci\u00f3 prim\u00e0ria","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","diabetis mellitus","eix cardiorenal metab\u00f2lic","farmac\u00e8utics","farmac\u00e8utics comunitaris","farmac\u00e8utiques","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","insufici\u00e8ncia card\u00edaca","insufici\u00e8ncia renal","pacient","pacient cardiorenal metab\u00f2lic","professionals sanitaris","Societat Catalana de Farm\u00e0cia Cl\u00ednica","Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","url":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","name":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","datePublished":"2024-11-18T10:02:47+00:00","dateModified":"2024-11-18T10:13:09+00:00","description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","width":2560,"height":1440,"caption":"Cristina Morales i Nuria Molist introduint la formaci\u00f3."},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 25 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\u201d amb el patrocini de Boehringer Ingelheim. La formaci\u00f3, adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries, va […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/79849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=79849"}],"version-history":[{"count":33,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/79849\/revisions"}],"predecessor-version":[{"id":79891,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/79849\/revisions\/79891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/79863"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=79849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=79849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=79849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}